Clinical significance and recent research advances of anti-VEGF treatment in ophthalmology
10.3980/j.issn.1672-5123.2020.2.20
- VernacularTitle:抗VEGF治疗在眼科的临床意义及研究进展
- Author:
Li Peng
1
Author Information
1. Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou People's Hospital, Haikou 570208, Hainan Province, China
- Publication Type:Journal Article
- Keywords:
anti-VEGF treatment;
ocular disease;
Ranibizumab;
Conbercept
- From:
International Eye Science
2020;20(2):282-285
- CountryChina
- Language:Chinese
-
Abstract:
Anti-vascular endothelial growth factor(VEGF)drugs have been used to treat various ophthalmic diseases, especially in the treatment of vascular proliferative ophthalmopathy. Anti-VEGF drugs can significantly inhibit the formation of new blood vessels and reduce retinal edema, thereby improving the patient's vision. However, their long-term therapeutic effect and safety require longer-term follow-up and research. This article reviews the application and research progress of anti-VEGF drugs in ophthalmology and provides references for clinical application and further research.
- Full text:202002020.PDF
